Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma

Noxa mediates p18INK4c cell-cycle control of homeostasis in B cells and plasma cell precursors

(2010) J. Bretz et al.   BLOOD

Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype

(2010) S. Montes-Moreno et al.   HAEMATOLOGICA

Decreased major histocompatibility complex class II expression in diffuse large B-cell lymphoma does not correlate with CpG methylation of class II transactivator promoters III and IV

(2010) Sarah T. Wilkinson et al.   LEUKEMIA & LYMPHOMA

MHC class II as a therapeutic target in B-cell lymphomas: the CIITA road to paradise?

(2010) Arjan Diepstra   LEUKEMIA & LYMPHOMA

Aggressive Lymphomas

(2010) Georg Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE

CIITA or RFX coding region loss of function mutations occur rarely in diffuse large B-cell lymphoma cases and cell lines with low levels of major histocompatibility complex class II expression

(2009) L. M. Rimsza et al.   HAEMATOLOGICA

Loss of HLA-DR expression and immunoblastic morphology predict adverse outcome in diffuse large B-cell lymphoma - analyses of cases from two prospective randomized clinical trials

(2009) H.-W. Bernd et al.   HAEMATOLOGICA

MHC II and the Endocytic Pathway: Regulation by Invariant Chain

(2009) O. J. B. Landsverk et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP

(2008) L. M. Rimsza et al.   BLOOD

Genomic alterations and gene expression in primary diffuse large B-cell lymphomas of immune-privileged sites: the importance of apoptosis and immunomodulatory pathways

(2008) M Booman et al.   JOURNAL OF PATHOLOGY